Product Description
| Download Documents | |
| Product Sheet | |
| SDS | COA_Lot#0531D |
MMAF (monomethyl auristatin F) is a new antimitotic auristatin derivative with a charged C-terminal phenylalanine residue. Mc-VC-PAB-MMAF is a thiol reactive derivative of MMAF that contains a cathepsin B cleavable valine-citruline p-aminobenzylcarbamate linkage (VC-PAB). This product is a control ADC for any IgG type antibody labeled with MMAF, particularly any ADC made using CellMosaic's Antibody MMAF Conjugation Kit (Cat#: CM11425 and Cat#: CM11422). The product uses a human IgG1 subtype antibody that does not bind to the target. It has an average of 3-5 MMAF loaded on each antibody and can be used for assessing the effect of MMAF alone (non-specific toxicity). The product uses a very low endotoxin level antibody as a starting material (≤0.5 EU/mg by the LAL method). The preparation and purification are conducted under a pyrogen free environment.
The final conjugate is lyophilized from pH 6.5 citrate buffer containing sugar-based stabilizer for easy shipping and storage.
The product is sold as 1 vial of 100 microgram (Cat# CM51101-100UG), 1 vial of 500 micrograms (Cat# CM51101-500UG), or 2 vials of 500 micrograms (Cat# CM51101-1MG). For bulk orders, please contact us for a quote.
Chemical Information
- Chemical name: ADC Control hIgG1-MMAF
- Chemical formula: N/A
- Molecular weight: 152KDa CAS number: N/A
Specification
- Physical Appearance: Colorless to white lyophilized powder in a microcentrifuge tube
- Storage Temp.: -20°C
- Purity: ≥99% of MMAF labeled antibody by SEC HPLC, free of any unreacted MMAF
- Endotoxin Level: ≤0.5 EU/mg by the LAL method
- Drug Over Antibody Ratio (DAR): 3 to 5 by UV ratio, HIC HPLC, and difference MALDI-TOF MS
Antibody Information
- Immunogen: HEL (Hen Egg Lysozyme)
- Species Reactivity: chicken
- Expression Host: CHO-S cell line
- Class: Human IgG1, Kappa
- Antibody Type: Monoclonal
- Applications: ELISA, FACS, IF, IHC, in vivo studies, IP, WB
- Purification Method: Affinity purified
Drug Information
- Name: Monomethyl auristatin F (MMAF) with Mc-VC-PAB linker
- CAS number: N/A
- Mechanism of action: Inhibits cell division by blocking the polymerization of tubulin. VC-PAB linker is stable in extracellular fluid but cleaved by cathepsin B once inside the tumor cell, activating the antimitotic mechanism.
- Activities: Antioxidant, anti-inflammatory, anticancer, and insecticidal activities.
- Selected References: 1) Doronina SO, Mendelsohn BA, Bovee TD, et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem 2006;17: 114–24. 2) Polson AG, et al. Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection. Cancer Res. 2009;69(6):2358−2364.
Frequently Asked Questions:
If you can’t find the answer you’re looking for or need information on general topics, please visit the main Frequently Asked Questions (FAQs) section.
Related Products
Antibody MMAF Conjugation Kit (With VC-PAB Linkage) (Product #: CM11425): ADC kit designed for labeling any IgG type antibody with MMAF using a cleavable VC-PAB linker for early-stage screening of customer's antibody.
Antibody Mc-MMAF Conjugation Kit (Product #: CM11422): ADC kit designed for labeling any IgG type antibody with MMAF with stable thiol ether bond for early-stage screening of customer's antibody.
